Mitchel Byron Harris

Mitchel Byron Harris

Auto-generated profile, based on publicly available information

Mitchel Byron Harris

Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2016 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
NPNuno Rui Paulino Pereira
Nuno Rui Paulino Pereira
SJStein J. Janssen
Stein J. Janssen
EDEva van Dijk
Eva van Dijk
MHMitchel B. Harris
Mitchel B. Harris
FHFrancis J. Hornicek
Francis J. Hornicek
JSJoseph H. Schwab
Joseph H. Schwab
Current prognostication models for survival estimation in patients with metastatic spine disease lack accuracy. Identifying new risk factors could improve existing models. We assessed factors associated with survival in patients surgically treated for spine metastases, created a classic scoring algorithm, nomogram, and boosting algorithm, and tested the predictive accuracy of the three created algorithms at estimating survival. We included 649 patients from two tertiary care referral centers in this retrospective study (2002 to 2014). A multivariate Cox model was used to identify factors independently associated with survival. We created a classic scoring system, a nomogram, and a boosting (i.e., machine learning) algorithm and calculated their accuracy by receiver operating characteristic analysis. Older age (hazard ratio [HR], 1.01; p = 0.009), poor performance status (HR, 1.54; p = 0.001), primary cancer type (HR, 1.68; p < 0.001), >1 spine metastasis (HR, 1.32; p = 0.009), lung and/or liver metastasis (HR, 1.35; p = 0.005), brain metastasis (HR, 1.90; p < 0.001), any systemic therapy for cancer prior to a surgical procedure (e.g., chemotherapy, immunotherapy, hormone therapy) (HR, 1.65; p < 0.001), higher white blood-cell count (HR, 1.03; p = 0.002), and lower hemoglobin levels (HR, 0.92; p = 0.009) were independently associated with decreased survival. The boosting algorithm was best at predicting survival on the training data sets (p < 0.001); the nomogram was more reliable at estimating survival on the test data sets, with an accuracy of 0.75 (30 days), 0.73 (90 days), and 0.75 (365 days). We identified risk factors associated with survival that should be considered in prognostication. Performance of the boosting algorithm and nomogram were comparable on the testing data sets. However, the nomogram is easier to apply and therefore more useful to aid surgical decision-making. Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

7 October 2005 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
JEJ. Kent Ellington
J. Kent Ellington
MHMitchel Harris
Mitchel Harris
MHMichael C. Hudson
Michael C. Hudson
SVSonia Vishin
Sonia Vishin
LWLawrence X. Webb
Lawrence X. Webb
RSRobert Sherertz
Robert Sherertz
Staphylococcus aureus is responsible for 80% of human osteomyelitis. It can invade and persist within osteoblasts. Antibiotic resistant strains of S. aureus make successful treatment of osteomyelitis difficult. Null Hypothesis: antibiotic sensitivities of S. aureus do not change after exposure to the osteoblast intracellular environment. Human and mouse osteoblast cultures were infected and S. aureus cells were allowed to invade. Following times 0, 12, 24, and 48 h ( ± the addition of erythromycin, clindamycin, and rifampin at times 0 or 12 h), the osteoblasts were lysed and intracellular bacteria enumerated. Transmission electron microscopy was performed on extracellular and intracellular S. aureus cells. In mouse osteoblasts, administration of bacteriostatic antibiotics at time 0 prevented the increase in intracellular S. aureus. If the antibiotics were delayed 12 h, this did not occur. When rifampin (bactericidal) was introduced at time 0 to human and mouse osteoblasts, there was a significant decrease in number of intracellular S. aureus within osteoblasts compared to control. If rifampin was delayed 12 h, this did not occur. Significant time‐dependent S. aureus structural changes were observed after exposure to the osteoblast intracellular environment. These studies demonstrate that once S. aureus is established intracellularly for 12 h, the bacteria are less sensitive to antibiotics capable of eukaryotic cell penetration (statistically significant). These antibiotic sensitivity changes could be due in part to the observed structural changes. This leads to the rejection of our null hypotheses that the antibiotic sensitivities of S. aureus are unaltered by their location. © 2005 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res

1 January 2012 in Spine
Verified
Journal Article
Closed access
JKJaehon M. Kim
Jaehon M. Kim
ELElena Losina
Elena Losina
CBChristopher M. Bono
Christopher M. Bono
ASAndrew Schoenfeld
Andrew Schoenfeld
JCJamie E. Collins
Jamie E. Collins
MHMitchel B. Harris
Mitchel B. Harris
Study Design. Systematic literature review from 1970 to 2007. Objective. This study reports the results of a systematic review comparing surgical decompression ± radiation to radiation therapy alone among patients with metastatic spinal cord compression. Summary of Background Data. Currently, the optimal treatment of metastatic spine lesions is not well defined and is inconsistent. Radiation and surgical excision are both accepted and effective. There appears to be a favorable trend for improved neurological outcome with surgical excision and stabilization as part of the management. Methods. A review of the English literature from 1970 to 2007 was performed in the Medline database using general MeSH terms. Relevant outcome studies for the treatment of metastatic spinal cord compression were selected through criteria defined a priori. The primary outcome was ambulatory capacity. A random effects model was built to compare results between treatment groups, based on calculated proportions from each study. Results. Of the 1595 articles screened, 33 studies (2495 patients) were selected based on our inclusion and exclusion criteria. Sixty-four percent of the patients who underwent surgical decompression, tumor excision, and stabilization had neurological improvement from nonambulatory to ambulatory status. Twenty-nine percent of the radiation therapy group regained the ability to ambulate after treatment (P < 0.001). Paraplegic patients had a 4-fold greater recovery rate to functional ambulation with surgical intervention than with radiation therapy alone (42% vs. 10%, P < 0.001). Pain relief was noted in 88% of the patients in the surgical studies and in 74% of the patients in studies of radiation therapy (P < 0.001). The overall surgical complication rate was 29%. Conclusion. This systematic review suggests that surgical excision of tumor and instrumented stabilization may improve clinical outcomes compared with radiation therapy alone, with regard to neurological function and pain. However, most data in the current literature are from observational studies, where variations in patient population and treatments cannot be controlled. This compromised our ability to compare the results of both treatments directly.

15 May 2011 in Spine
Verified
Journal Article
Closed access
ASAndrew Schoenfeld
Andrew Schoenfeld
CBChristopher M. Bono
Christopher M. Bono
WRWilliam M. Reichmann
William M. Reichmann
NWNatalie Warholic
Natalie Warholic
KWKirkham B. Wood
Kirkham B. Wood
MHMitchel B. Harris
Mitchel B. Harris
Study Design. Retrospective cohort study. Objective. To determine the influence of age, comorbidities, and treatment type on mortality in elderly patients with acute Type II odontoid fractures. Summary of Background Data. Prior studies have documented increased morbidity and mortality among geriatric patients sustaining odontoid fractures. However, there is limited data regarding the effect of patient age, medical comorbidities, and treatment selection on mortality after Type II odontoid (C2) fractures in the elderly. Methods. An institutional registry was used to identify all Type II odontoid fractures sustained by patients aged 65 and older from 1991 to 2006. Demographic information, date of injury, associated injuries, treatment type, and comorbidities were abstracted from medical records. Mortality was ascertained using the National Death Index. Risks of mortality and their associated 95% confidence intervals (CIs) were calculated at 3 months, 1 year, 2 years, and 3 years. Multivariable Cox proportional hazard regression was used to evaluate independent factors affecting mortality stratified by age (65–74 years, 75–84 years, ≥85 years) and treatment type (operative or nonoperative treatment, and halo or collar immobilization). Results. Of 156 patients identified with Type II odontoid fracture, the average age was 82 years (SD = 7.8; Range: 65–101). One hundred and twelve patients (72%) were treated nonoperatively. At 3 years postinjury, there was a 39% (95% CI: 32–47) mortality rate for the entire cohort. Mortality for the operative group was 11% (95% CI: 2–21) at 3 months and 21% (95% CI: 9–32) at 1 year compared with 25% (95% CI: 17–33) at 3 months and 36% (95% CI: 27–45) at 1 year in the nonoperative group. The Cox regression model showed that the protective effect of surgery was seen in patients aged 65 to 74 years, in whom the hazard ratio associated with surgery for mortality after odontoid fracture was 0.4 (95% CI: 0.1–1.5). Those aged 75 to 84 years had a hazard ratio of 0.8 (95% CI: 0.3–2.3), and patients 85 years or older had a hazard ratio of 1.9 (95% CI: 0.6–6.1; P value for interaction between age and treatment = 0.09) with operative treatment having a protective effect in patients aged 65 to 74 years. Conclusion. In a cohort of elderly patients, Type II odontoid fractures were associated with a high rate of mortality, regardless of intervention.

1 November 2015 in The Spine Journal
Verified
Journal Article
Closed access
AGAhmer K. Ghori
Ahmer K. Ghori
DLDana A. Leonard
Dana A. Leonard
ASAndrew Schoenfeld
Andrew Schoenfeld
ESEhsan Saadat
Ehsan Saadat
NSNathan Scott
Nathan Scott
MHMitchel B. Harris
Mitchel B. Harris

1 March 2010 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MHMitchel B Harris
Mitchel B Harris
WRWilliam M Reichmann
William M Reichmann
CBChristopher M Bono
Christopher M Bono
KBKim Bouchard
Kim Bouchard
KCKelly L Corbett
Kelly L Corbett
JKJeffrey N Katz
Jeffrey N Katz
Ated with cervical spine fractures in patients sixty-five years of age or older and to evaluate potential factors that may influence mortality. Methods: We performed a retrospective review of all cervical spine fractures in patients sixty-five years of age or older from 1991 to 2006 at two institutions. Information regarding age, sex, race, treatment type, neurological involvement, injury mechanism, comorbidity, and mortality were collected. Overall risk of mortality and mortality stratified by the above factors were calculated at three months and one year. Cox proportional-hazard regression was performed to identify independent correlates of mortality. Results: Six hundred and forty patients were included in our analysis. The mean age was eighty years (range, sixty-five to 101 years). Two hundred and ninety-four patients (46%) were male, and 116 (18%) were nonwhite. The risk of mortality was 19% at three months and 28% at one year. The effect of treatment on mortality varied with age at three months (p for interaction = 0.03) but not at one year (p for interaction = 0.08), with operative treatment being associated with less mortality for those between the ages of sixty-five and seventy-four years. A higher Charlson comorbidity score, male sex, and neurological involvement were all associated with increased risk of mortality. Conclusions: Operative treatment of cervical spine fractures is associated with a lower mortality rate at three months but not at one year postoperatively for patients between sixty-five and seventy-four years old at the time of fracture. Level of Evidence: Prognostic Level II. See Instructions to Authors for a complete description of levels of evidence....